This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange declined 2.62 points to 697.55 Wednesday. Ronald Schmeichel has a new capital pool shell, Mira VII Acquisition Corp. (MVA), which lists on the TSX-V Thursday. It is the first capital pool shell to list in April and the sixth this year. This is busier than last year at this time when just four capital pool shells had listed. Richardson GMP Ltd. sold Mira VII's $250,000 initial public offering of 2.5 million shares at 10 cents. This is the second capital pool shell Richardson has listed this year, the first being Amar Bhalla's Carlaw Capital V Corp. (CVC), which went public at 20 cents in February.

Last month, Mira VII sold 10 million escrow shares at five cents to its three directors, Mr. Schmeichel, Jordan Kupinsky and Kevin Taylor. Mr. Schmeichel, Mira VII's president and the busiest shell-maker in Canada these days, owns four million escrow shares. We reported on his record in detail in the Shell Summary for April 1, concluding that he has completed qualifying transactions for 15 capital pool shells, yielding an impressive record of 13 successes and two failures. We consider a QT a success if an IPO shareholder is able to sell his position at a profit within a year or two of the deal closing. Mr. Schmeichel's most recent QT was a reverse takeover of Steve Chung's Frankly Inc. (TLK: $2.88), a social networking company and app-maker that went public last January. Mr. Schmeichel also has two other capital pool shells, Mira IV Capital Acquisition Corp. (MRY) and Mira VI Acquisition Corp. (MVI), both halted and planning QTs. Mira IV hopes to buy a medical device company and Mira VI is working on a deal with an app developer that tries to increase its number of users by offering loyalty points. Mr. Schmeichel also maintains close ties to the TSX-V as a member of the Ontario advisory committee for listings, which allows him to keep a close eye on himself.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS